Avanos Medical appoints Indrani Franchini to Board

Avanos Medical, Inc. (NYSE: AVNS) has recently appointed Indrani Franchini as a new independent member of their board of directors. Franchini brings a wealth of experience from her previous roles, including her time as the Executive Vice President and Chief Legal Officer at Alnylam Pharmaceuticals and as the Executive Vice President and Chief Compliance Officer at Alexion Pharmaceuticals, Inc.

With this new addition, the Avanos board now comprises six directors, five of whom are independent, including three women, two of whom are ethnically diverse.

Avanos Medical, Inc. is a medical technology company that is committed to addressing important healthcare needs. They focus on delivering clinically superior medical device solutions that help patients recover and return to their normal lives. The company is headquartered in Alpharetta, Georgia.

This appointment reflects the company's commitment to bringing diverse and experienced perspectives to their board to support their vision of helping patients get back to the things that matter. Following these announcements, the company's shares moved -1.0%, and are now trading at a price of $19.72. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.